The role of Small Intestinal Bacterial Overgrowth (SIBO) in Non-alcoholic Fatty Liver Disease (NAFLD) patients evaluated using Controlled Attenuation Parameter (CAP) Transient Elastography (TE): a tertiary referral center experience.

Yoga FitriakusumahCosmas Rinaldi Adithya LesmanaWinda Permata BastianChyntia O M JasirwanIrsan HasanMarcellus SimadibrataJuferdy KurniawanAndri Sanityoso SulaimanRino A Gani

Published in: BMC gastroenterology (2019)

SIBO is not associated with NAFLD development and progression.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
primary care
peritoneal dialysis
liver fibrosis
prognostic factors